SPIA
AMRX icon

Steward Partners Investment Advisory’s Amneal Pharmaceuticals AMRX Stock Holding History

Steward Partners Investment Advisory’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35 Buy
+2
New +$27 ﹤0.01% 4599
2024
Q1 		– Sell
-37
Closed -$225 – 3563
2023
Q4 		$225 Buy
+37
New +$165 ﹤0.01% 3407
2019
Q3 		– Sell
-181
Closed -$1K – 2608
2019
Q2 		$1K Buy
+181
New +$1.85K ﹤0.01% 2502
2018
Q4 		– Sell
-181
Closed -$4K – 835
2018
Q3 		$4K Buy
+181
New +$3.81K ﹤0.01% 2169

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Steward Partners Investment Advisory's AMRX Position: Q2 2026 in Review

Steward Partners Investment Advisory opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 2 shares worth $35. The stake represents ﹤0.01% of the portfolio and ranks #4599 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in AMRX as recently as Q4 2023.

Steward Partners Investment Advisory first reported a position in AMRX in Q3 2018 and has held it in 4 quarters since. The position peaked at $4K in Q3 2018. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Steward Partners Investment Advisory held 2 shares of Amneal Pharmaceuticals worth $35 as of Q2 2026.
  • Amneal Pharmaceuticals was a new Steward Partners Investment Advisory position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4599 holding.
  • Steward Partners Investment Advisory first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 4 quarters since.
  • Steward Partners Investment Advisory's Amneal Pharmaceuticals position peaked at $4K in Q3 2018.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.